4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0001209191-19-013558
Chief Scientific Officer sold 11,485 shares at $4.25 ($48,853)
- Chief Scientific Officer acquired 11,485 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ettenberg Seth Chief Scientific Officer | 2019-02-25 | Option exercise | +11,485 | $0.18 | $2,067 | 11,485 | D |
| Ettenberg Seth Chief Scientific Officer | 2019-02-25 | Sale | −11,485 | $4.25 | $48,853 | 0 | D |
| Derivatives | |||||||
| Ettenberg Seth Chief Scientific Officer | 2019-02-25 | Option exercise · Stock Option (Right to Buy) | −11,485 | 340,630 | D | ||
| Open-market sales · 11,485 sh · avg $4.25 · $48,853 | |||||||
Loading xslF345X03/doc4.xml…